DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)-based quadruplet regimen approved in the U.S. for patients with newly diagnosed multiple myeloma who are transplant-eligible
Findings from first-ever quadruplet therapy study with subcutaneous DARZALEX FASPRO® showed 60 percent reduction in risk of disease progression or death New regimen solidifies DARZALEX FASPRO® as a foundational frontline therapy in multiple myeloma with potential to significantly delay disease pr
California Chooses to Bypass the Administrative Process and Sue Taxpayers in Superior Court
Business Owners Need to Be Vigilant in Order to Protect Their Rights, Says CA Law Firm Brotman Law SAN DIEGO, July 30, 2024 /PRNewswire/ — California tax agencies, such as the Employment Development Department (EDD) and the California Department of Tax and Fee Administration (CDTFA), have ra
Telehealth Market size is set to grow by USD 368.7 billion from 2024-2028, Increasing cases of chronic diseases boost the market, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ — The global telehealth market size is estimated to grow by USD 368.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 40.06% during the forecast period. Increasing cases of chronic diseases is driving marke
T. ROWE PRICE GROUP DECLARES QUARTERLY DIVIDEND
BALTIMORE, July 30, 2024 /PRNewswire/ — T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced today that its Board of Directors has declared a quarterly dividend of $1.24 per share payable September 27, 2024, to stockholders of record as of the close of business on September 13, 2024. ABOUT T
NASA Sets Coverage for Northrop Grumman’s 21st Station Resupply Launch
WASHINGTON, July 30, 2024 /PRNewswire/ — NASA, Northrop Grumman, and SpaceX are targeting 11:28 a.m. EDT on Saturday, Aug. 3, for the next launch to deliver science investigations, supplies, and equipment to the International Space Station. This launch is the 21st Northrop Grumman commercial
Synthetic Biology Market size is set to grow by USD 55.60 BILLIOn from 2024-2028, growing applications leading to growing adoption of synthetic biology boost the market, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ — The global synthetic biology market size is estimated to grow by USD 55.60 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 34.1% during the forecast period. Growing applications leading to growing adopti
Healthcare IT Market size is set to grow by USD 199.8 billion from 2024-2028, Increasing focus on improving quality of services and efficiency to boost the market growth, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ — The global healthcare IT market size is estimated to grow by USD 199.8 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 11.61% during the forecast period. Increasing focus on improving quality of service
3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio
NEW YORK, July 30, 2024 /PRNewswire/ — The global 3D printing medical devices market size is estimated to grow by USD 7.07 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 25.2% during the forecast period. Increased demand for personalized
Coastal Plains Community MHMR Center Provides Notice of Security Incident
PORTLAND, Texas, July 30, 2024 /PRNewswire/ — Coastal Plains Community MHMR Center (d/b/a Coastal Plains Community Center and Coastal Plains Integrated Health) (“Coastal Plains”), a provider of mental health, developmental disabilities, substance use, and primary care services, con
Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, July 30, 2024 /PRNewswire/ — Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced that it has granted inducement equity awards on July 29, 2024 to its newly-hired Chief Executive Officer, Joel D. Anderson, as a material inducement to the employment of Mr. Anderson.
